| dc.contributor.author | Fragoso, Y. D. | |
| dc.contributor.author | Spelman, T. | |
| dc.contributor.author | Duquette, P. | |
| dc.contributor.author | Girard, M. | |
| dc.contributor.author | Trojano, M. | |
| dc.contributor.author | Izquierdo, G. | |
| dc.contributor.author | Butzkueven, H. | |
| dc.date.accessioned | 2020-06-21T13:18:04Z | |
| dc.date.available | 2020-06-21T13:18:04Z | |
| dc.date.issued | 2017 | |
| dc.identifier.issn | 1352-4585 | |
| dc.identifier.issn | 1477-0970 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/12191 | |
| dc.description | 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) -- OCT 25-28, 2017 -- Paris, FRANCE | en_US |
| dc.description | Oreja-Guevara, Celia/0000-0002-9221-5716; Lugaresi, Alessandra/0000-0003-2902-5589 | en_US |
| dc.description | WOS: 000413730205114 | en_US |
| dc.description.abstract | … | en_US |
| dc.description.sponsorship | European Comm Treatment & Res Multiple Sclerosis, Americas Comm Treatment & Res Multiple Sclerosis | en_US |
| dc.description.sponsorship | Biogen IdecBiogen; NovartisNovartis; MerckSeronoMerck SeronoMerck & Company; GenzymeGenzyme Corporation | en_US |
| dc.description.sponsorship | Yara Dadalti Fragoso, Tim Spelman, Pierre Duquette, Marc Girard, Maria Trojano, Guillermo Izquierdo, Pierre Grammond, Alessandra Lugaresi, Vincent Van Pesch, Francois Grand'Maison, Celia Oreja-Guevara, Gerardo Iuliano, Roberto Bergamaschi, Maria Edite Rio, Ricardo Fernandez Bolanos, Murat Terzi, and Helmut Butzkueven, have no particular conflicts of interest to declare for this abstract. The work was carried out on behalf of MSBase study group, which receives unconditional grants from pharmaceutical industries (Biogen Idec, Novartis, MerckSerono, Genzyme) to support the existence of the database. | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Sage Publications Ltd | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Halting disability progression in multiple sclerosis with immunomodulatory injectable treatments: Is it achievable? | en_US |
| dc.type | conferenceObject | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 23 | en_US |
| dc.identifier.startpage | 854 | en_US |
| dc.identifier.endpage | 855 | en_US |
| dc.relation.journal | Multiple Sclerosis Journal | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
